JP2016527247A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527247A5
JP2016527247A5 JP2016528615A JP2016528615A JP2016527247A5 JP 2016527247 A5 JP2016527247 A5 JP 2016527247A5 JP 2016528615 A JP2016528615 A JP 2016528615A JP 2016528615 A JP2016528615 A JP 2016528615A JP 2016527247 A5 JP2016527247 A5 JP 2016527247A5
Authority
JP
Japan
Prior art keywords
solvent
pancreatin
usp
organic solvent
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016528615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/002583 external-priority patent/WO2015019198A2/en
Publication of JP2016527247A publication Critical patent/JP2016527247A/ja
Publication of JP2016527247A5 publication Critical patent/JP2016527247A5/ja
Pending legal-status Critical Current

Links

JP2016528615A 2013-07-22 2014-07-15 高力価パンクレアチン医薬組成物 Pending JP2016527247A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361856952P 2013-07-22 2013-07-22
US61/856,952 2013-07-22
PCT/IB2014/002583 WO2015019198A2 (en) 2013-07-22 2014-07-15 High potency pancreatin pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2016527247A JP2016527247A (ja) 2016-09-08
JP2016527247A5 true JP2016527247A5 (enExample) 2017-07-13

Family

ID=52117920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016528615A Pending JP2016527247A (ja) 2013-07-22 2014-07-15 高力価パンクレアチン医薬組成物

Country Status (13)

Country Link
US (2) US20160152968A1 (enExample)
EP (1) EP3024479B2 (enExample)
JP (1) JP2016527247A (enExample)
KR (1) KR20160055123A (enExample)
CN (1) CN105392496A (enExample)
AU (1) AU2014304176A1 (enExample)
BR (1) BR112016001289A2 (enExample)
CA (1) CA2919114A1 (enExample)
ES (1) ES2743212T5 (enExample)
IL (1) IL243627A (enExample)
MX (1) MX2016000794A (enExample)
RU (1) RU2686460C2 (enExample)
WO (1) WO2015019198A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
AU2008218595B2 (en) 2007-02-20 2012-05-24 Allergan Therapeutics LLC Stable digestive enzyme compositions
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
MX351014B (es) 2011-08-08 2017-09-28 Aptalis Pharma Ltd Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas.
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
CN106163544A (zh) 2013-08-09 2016-11-23 阿勒根制药国际有限公司 适于经肠施用的消化酶组合物
CN106659773A (zh) * 2013-11-05 2017-05-10 阿勒根制药国际有限公司 高效的胰酶药物组合物
ES2970869T3 (es) * 2016-03-28 2024-05-31 Abbott Laboratories Gmbh Composiciones enzimáticas con contaminación vírica y microbiana reducida
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
US11291236B2 (en) * 2017-09-11 2022-04-05 Alcresta Therapeutics, Inc. Devices and methods for the preparation of a nutritional formula
EA202090851A1 (ru) * 2017-09-27 2020-08-07 Эбботт Лэбораториз Гмбх Ферментные композиции со сниженным уровнем вирусного и микробного загрязнения
CN111394275B (zh) * 2020-02-22 2022-05-27 华东师范大学 一株解淀粉芽孢杆菌及其应用、水产饲料和水产养殖方法
FR3111559A1 (fr) * 2020-06-18 2021-12-24 Azurrx Biopharma, Inc. Formulations non porcines et leurs procédés

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928654A (en) 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
US3168448A (en) * 1963-01-07 1965-02-02 Wilson & Co Inc Process of preparing a lipolytic enzyme composition
DE3377506D1 (en) * 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
DE69634248T2 (de) 1995-05-31 2006-01-12 Medzyme N.V. Zusammensetzungen zur verbesserung der verdaulichkeit und ausnutzung von nähestoffen
KR19990072826A (ko) * 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
SI1809320T1 (sl) 2004-10-14 2010-11-30 Cystic Fibrosis Foundation Therapeutics Inc Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience
RU2445952C2 (ru) * 2007-02-20 2012-03-27 Юранд Фармасьютикалз Лимитед Стабильные композиции пищеварительных ферментов
EP2547765A4 (en) * 2010-03-19 2013-09-04 Aptalis Pharma Canada Inc BETA-PROPIOLACTONE FOR INACTIVATING VIRUSES IN PANCREATIC PHARMACEUTICAL ENZYMATIC PREPARATIONS
MX351014B (es) * 2011-08-08 2017-09-28 Aptalis Pharma Ltd Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas.
JP2013071929A (ja) * 2011-09-29 2013-04-22 Kobayashi Pharmaceutical Co Ltd 胃腸薬
CN106163544A (zh) * 2013-08-09 2016-11-23 阿勒根制药国际有限公司 适于经肠施用的消化酶组合物
CN106659773A (zh) 2013-11-05 2017-05-10 阿勒根制药国际有限公司 高效的胰酶药物组合物

Similar Documents

Publication Publication Date Title
RU2686460C2 (ru) Высокоэффективные фармацевтические композиции панкреатина
Ali et al. Recovery and partial purification of fibrinolytic enzymes of Auricularia polytricha (Mont.) Sacc by an aqueous two-phase system
IL274583A (en) Pancreatin pharmacological preparations with high potency
Afrin et al. Eritadenine from edible mushrooms inhibits activity of angiotensin converting enzyme in vitro
US10184121B2 (en) Methods for removing viral contaminants from pancreatic extracts
JP6109881B2 (ja) 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法
JP2020531627A (ja) チュウゴクオオサンショウウオ軟骨製剤
Lozano-Ojalvo et al. Hypoallergenic hydrolysates of egg white proteins modulate allergen responses induced ex vivo on spleen cells from sensitized mice
US4645667A (en) Antitumor agent and process for manufacturing said agent
CN106879884B (zh) 一种提高蜂王浆性能的方法
US20200255817A1 (en) High potency pancreatin pharmaceutical compositions
CN110218717B (zh) 一种灵芝多糖的制备方法及其对超氧化物歧化酶干燥失活的保护作用
RU2839164C1 (ru) Способ получения ферментолизата биомассы метанокисляющих бактерий
CN118547032A (zh) 降血脂蛋白水解物、肽及其制备方法和应用
He et al. Wild Cordyceps proteins reinforce intestinal epithelial barrier through MAPK/NF-κB pathway in MRL/lpr mice
WO2026082817A1 (en) Polypeptides having alkaline phosphatase activity for use in treatment of inflammatory and metabolic diseases